5.96
price down icon6.58%   -0.42
after-market Handel nachbörslich: 5.78 -0.18 -3.02%
loading

Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
8.23%
1.1247
1.2255 0.9391 0.4843 1.0198
Operating Income/Loss
5.22%
-2.3414
-2.4702 -1.9037 -1.6389 -1.8987
Nonoperating Income/Loss
61.26%
0.0937
0.2419 0.1543 0.0492 0.2814
Income/Loss From Continuing Operations Before Tax
0.87%
-2.2477
-2.2284 -1.7495 -1.5896 -1.6173
Income/Loss From Continuing Operations After Tax
0.87%
-2.2477
-2.2284 -1.7495 -1.5904 -1.6173
Net Income/Loss
0.87%
-2.2477
-2.2284 -1.7495 -1.5904 -1.6173
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,636%
7.9725
0.4594 7.0227 5.3058 -0.9911
Basic Earnings Per Share
12.50%
-0.28
-0.32 -0.25 -0.30 -0.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):